Fulgent Genetics (FLGT) Other financing activities (2017 - 2026)

Fulgent Genetics (FLGT) posted Other financing activities of $2000.0 for Q2 2026, down 77.78% sequentially from $9000.0 in Q1 2026.

Fulgent Genetics (FLGT) Other financing activities (2017 - 2026) Analysis & Trends

Fulgent Genetics has reported Other financing activities for 7 years, with the latest figure at $2000.0 in Q2 2026.

Quarterly Other financing activities changed N/A year-over-year to $2000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11000.0 (changed N/A YoY) and the FY2025 annual result came in at $1000.0, down 98.04% from the prior year.
Other financing activities fell to $2000.0 in Q2 2026 per FLGT's latest filing, from $9000.0 in the prior quarter.
Over five years, Other financing activities peaked at $16000.0 in Q1 2022 and troughed at $2000.0 in Q2 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Fulgent Genetics	557.44 Mn	300.41 Mn	25.68 Mn

Download Data